This Pharma.Aero white paper builds on insights from the recent Industry Briefing on geopolitical instability in the Gulf and its impact on life science supply chains. It examines how ongoing disruptions affect global pharmaceutical logistics, including air cargo route constraints, increased transit times, and heightened risks for temperature-sensitive shipments. The report outlines strategic responses for industry stakeholders, focusing on resilience, risk mitigation, and operational continuity in an increasingly volatile environment.
Geopolitical Instability in the Gulf: Pharma Supply Chain Impact
